Metabolic Syndrome Prevalence in Renal Cell Cancer Patients |
Bulut, Suleyman
(Urology Clinic, Ankara Numune Education and Research Hospital)
Aktas, Binhan Kagan (Urology Clinic, Ankara Numune Education and Research Hospital) Erkmen, Akif Ersoy (Urology Clinic, Ankara Numune Education and Research Hospital) Ozden, Cuneyt (Urology Clinic, Ankara Numune Education and Research Hospital) Gokkaya, Cevdet Serkan (Urology Clinic, Ankara Numune Education and Research Hospital) Baykam, Mehmet Murat (Urology Clinic, Ankara Numune Education and Research Hospital) Memis, Ali (Urology Clinic, Ankara Numune Education and Research Hospital) |
1 | Ford ES, Giles WH, Dietz WH (2002). Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA, 287, 356-9. DOI ScienceOn |
2 | Forootan M, Tabatabaeefar M, Yahyaei M, Maghsoodi N (2012). Metabolic syndrome and colorectal cancer: a cross-sectional survey. Asian Pac J Cancer Prev, 13, 4999-5002. 과학기술학회마을 DOI ScienceOn |
3 | Fraeman KH, Nordstrom BL, Luo W, Landis SH, Shantakumar S (2013). Incidence of new-onset hypertension in cancer patients, a retrospective cohort study. Int J Hypertens, 2013, 379252. |
4 | Grundy SM, Cleeman JI, Daniels SR, et al (2005). American heart association, national heart, lung, and blood institute. diagnosis and management of the metabolic syndrome, an American heart association/national heart, lung and blood institute scientific statement. Circulation, 112, 2735-52. DOI ScienceOn |
5 | Guo YZ, Pan L, Du CJ, Ren DQ, Xie XM (2013). Association between C-reactive protein and risk of cancer: a metaanalysis of prospective cohort studies. Asian Pac J Cancer Prev, 14, 243-8. DOI ScienceOn |
6 | Hammarsten J, Peeker R (2011). Urological aspects of the metabolic syndrome. Nat Rev Urol, 8, 483-94. DOI ScienceOn |
7 | Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics. CA Cancer J Clin, 60, 277-300. DOI |
8 | Jonasch E, Futreal PA, Davis IJ, et al (2012). State of the science, an update on renal cell carcinoma. Mol Cancer Res, 10, 859-80. DOI |
9 | Kaneko R, Sato Y, An Y, et al (2010). Clinico-epidemiologic study of the metabolic syndrome and lifestyle factors associated with the risk of colon adenoma and adenocarcinoma. Asian Pac J Cancer Prev, 11, 975-83. |
10 | Linehan WM, Ricketts CJ (2013). The metabolic basis of kidney cancer. Semin Cancer Biol, 23, 46-55. DOI ScienceOn |
11 | Morita T, Tabata S, Mineshita M, et al (2005). The metabolic syndrome is associated with increased risk of colorectal adenoma development, the self-defense forces health study. Asian Pac J Cancer Prev, 6, 485-9. |
12 | Ozbek E, Otunctemur A, Dursun M, et al (2014). Association between the metabolic syndrome and high tumor grade and stage of primary urothelial cell carcinoma of the bladder. Asian Pac J Cancer Prev, 15, 1447-51. 과학기술학회마을 DOI ScienceOn |
13 | Navai N, Wood CG (2012). Environmental and modifiable risk factors in renal cell carcinoma. Urol Oncol, 30, 220-4. DOI ScienceOn |
14 | Otunctemur A, Ozbek E, Sahin S, et al (2014). Diabetes mellitus as a risk factor for high grade renal cell carcinoma. Asian Pac J Cancer Prev, 15, 3993-6. 과학기술학회마을 DOI ScienceOn |
15 | Ozbek E, Otunctemur A, Sahin S, et al (2013). Renal cell carcinoma is more aggressive in Turkish patients with the metabolic syndrome. Asian Pac J Cancer Prev, 14, 7351-4. 과학기술학회마을 DOI ScienceOn |
16 | Ozbek E, Otunctemur A, Dursun M, et al (2014). The metabolic syndrome is associated with more aggressive prostate cancer. Asian Pac J Cancer Prev, 15, 4029-32. 과학기술학회마을 DOI ScienceOn |
17 | Pothiwala P, Jain SK, Yaturu S (2009). Metabolic syndrome and cancer. Metab Syndr Relat Disord, 7, 279-88. DOI ScienceOn |
18 | Ulaganathan V, Kandiah M, Zalilah MS, et al (2012). Colorectal cancer and its association with the metabolic syndrome, a Malaysian multi-centric case-control study. Asian Pac J Cancer Prev, 13, 3873-7. 과학기술학회마을 DOI ScienceOn |
19 | Protzel C, Maruschke M, Hakenberg OW (2012). Epidemiology, aetiology and pathogenesis of renal cell carcinoma. Eur Urol Supp, 11, 52-9. DOI ScienceOn |
20 | Ronco AL, De Stefani E, Deneo-Pellegrini H, Quarneti A (2012). Diabetes, overweight and risk of postmenopausal breast cancer, a case-control study in Uruguay. Asian Pac J Cancer Prev, 13, 139-46. 과학기술학회마을 DOI ScienceOn |
21 | Van Hemelrijck M, Garmo H, Hammar N, et al (2012). The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study. Int J Cancer, 130, 2118-28. DOI ScienceOn |
22 | Zhu Y, Wang HK, Zhang HL, et al (2013). Visceral obesity and risk of high grade disease in clinical t1a renal cell carcinoma. J Urol, 189, 447-53. DOI ScienceOn |
23 | Weikert S, Boeing H, Pischon T, et al. (2008). Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. Am J Epidemiol, 167, 438-46. DOI ScienceOn |
24 | Weikert S, Ljungberg B (2010). Contemporary epidemiology of renal cell carcinoma, perspectives of primary prevention. World J Urol, 28, 247-52. DOI ScienceOn |
25 | Wu Q, He XD, Yu L, Liu W, Tao LY (2012). The metabolic syndrome and risk factors for biliary tract cancer, a case-control study in China. Asian Pac J Cancer Prev, 13, 1963-9. 과학기술학회마을 DOI ScienceOn |
26 | Faul F, Erdfelder E, Buchner A, Lang AG (2009). Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods, 41, 1149-60. DOI ScienceOn |
27 | Azeem K, Kollarova H, Horakova D, Magnuskova S, Janout V (2011). Genetic syndromes associated with renal cell carcinoma: a review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 155, 231-8. DOI |
28 | Alberti KG, Zimmet P, Shaw J (2005). IDF Epidemiology task force consensus group. the metabolic syndrome-a new worldwide definition. Lancet, 366, 1059-62. DOI ScienceOn |
29 | Brock K, Gridley G, Lynch C, Ershow A, Cantor K (2007). Obesity and hypertension interact to increase risk of renal cell carcinoma in Iowa, USA. Obes Res Clin Pract, 1, 1-2. DOI ScienceOn |
30 | Ferlay J, Shin HR, Bray F, et al (2008). Estimates of worldwide burden of cancer in 2008: GLOBOCAN. Int J Cancer, 127, 2893-917. |
31 | Haggstrom C, Rapp K, Stocks T, et al (2013). Metabolic factors associated with risk of renal cell carcinoma. PLoS One, 8, 57475. DOI |
![]() |